JPS59110628A - Preparation of drug coated with coating soluble in stomach - Google Patents
Preparation of drug coated with coating soluble in stomachInfo
- Publication number
- JPS59110628A JPS59110628A JP22260582A JP22260582A JPS59110628A JP S59110628 A JPS59110628 A JP S59110628A JP 22260582 A JP22260582 A JP 22260582A JP 22260582 A JP22260582 A JP 22260582A JP S59110628 A JPS59110628 A JP S59110628A
- Authority
- JP
- Japan
- Prior art keywords
- coating
- acid
- coated
- solution
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
Abstract
Description
【発明の詳細な説明】
本発明は水性コーティングによる胃溶性被覆薬剤の製造
方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing gastrosoluble coated drugs by aqueous coating.
従来より、苫味を有する薬剤の若株マスキング方法とじ
では、一般的にポリビニルアセタールジエチルアミノア
セテート(AEA)、メチルビニルピリジンメチルアク
リレートメタクリル酸共重合体(MPM)、セルロース
アセテートジブチルアミノヒドロキシプロピルエーテル
(CARP)、ジメチルアミノエチルメタクリレート−
メチルメタクリレート共重合体(オイドラギッPE)等
の水不溶性皮膜剤(胃溶性皮膜剤)をコーティングする
手法がとられでいるが、これらの皮膜剤は水には溶解し
ないため、一般に揮発性の大きい有機溶媒に溶解してス
プレーコーティングが行なわれでいるのが実状である。Conventionally, methods for masking young plants of drugs that have a bitter taste generally include polyvinyl acetal diethylamino acetate (AEA), methyl vinyl pyridine methyl acrylate methacrylic acid copolymer (MPM), and cellulose acetate dibutylamino hydroxypropyl ether (CARP). ), dimethylaminoethyl methacrylate-
Coating methods have been taken with water-insoluble coating agents (gastric soluble coating agents) such as methyl methacrylate copolymer (Eudragit PE), but since these coating agents do not dissolve in water, they are generally coated with highly volatile organic In reality, spray coating is performed by dissolving it in a solvent.
しかし、近時、有機溶媒を用いた医薬品等のコーティン
グは労働安全衛生面における作業環境問題、大気汚染等
の公害規制の問題、あるいは医薬品に残留する溶媒規制
の問題等々、いろいろな制約が生じ、最も安全で且、環
境を損なわない水性溶媒への切替えが要請されるように
なった。However, in recent years, the coating of pharmaceutical products using organic solvents has come with various restrictions, such as work environment issues in terms of occupational safety and health, pollution regulations such as air pollution, and regulations regarding solvents remaining in pharmaceuticals. There is now a demand for switching to aqueous solvents, which are the safest and do not harm the environment.
以上のような問題点は、コーティング溶媒として水性溶
媒を使用することにより解決できるが、水に不溶で酸に
可溶゛で酸に可溶な皮膜剤の水性コーティングについて
は、これまでに有効な方法は見い出さnていなかった。The above problems can be solved by using an aqueous solvent as a coating solvent, but so far there have been no effective aqueous coatings with film agents that are insoluble in water and soluble in acids. I haven't found a way.
最近にケっで薬剤のマスキング効果を目的とした水不溶
性皮膜剤の水性コーティング剤としてアクリル樹脂−水
分散剤のオイドラギッ^ティング作業が難かしく且、コ
ーテイング品においてもコーテイング液の乳化分散剤(
ホリソルベート80)に起因すると思われる服用時の不
快な味の発現等の欠点を有し、必らずしも十分満足でき
るコーティング剤ではなかった。Recently, it has become difficult to work with acrylic resin-water dispersant as an aqueous coating agent for water-insoluble film agents aimed at masking effects of chemicals, and in coating products, emulsifying and dispersing agents in coating liquids (
It had drawbacks such as the development of an unpleasant taste when taken, which was thought to be caused by folysorbate 80), and was not necessarily a fully satisfactory coating agent.
そこで、本発明者等はAEA、MPM、CAHP、オイ
ドラギット%等の水に不溶で、胃液に可溶な高分子皮膜
剤の水性コーティングの可能性について鋭意検討を加え
た結果、これらの皮膜剤が、酸性域で溶解する特性を有
する点に着目し、酸を溶解した水を用いれば、これらの
皮膜剤を溶解することを見い出し本発明を完成した。Therefore, the present inventors conducted extensive studies on the possibility of water-based coating with polymer coating agents such as AEA, MPM, CAHP, Eudragit%, etc., which are insoluble in water and soluble in gastric fluid. They focused on the fact that they have the property of dissolving in an acidic region, and discovered that these coating agents could be dissolved by using water in which an acid was dissolved, thereby completing the present invention.
本発明において使用さnる酸としては、たとえばクエン
酸、酒石酸、コハク酸、グルコン酸、リンゴ酸、フマル
酸、乳酸、酢酸等の有機酸あるいは塩酸、硫酸等の無機
酸を挙げることができるが、有機酸を用いるのが好まし
い。Examples of the acid used in the present invention include organic acids such as citric acid, tartaric acid, succinic acid, gluconic acid, malic acid, fumaric acid, lactic acid, and acetic acid, and inorganic acids such as hydrochloric acid and sulfuric acid. , it is preferable to use organic acids.
ここで、酸を含有しr、=水溶液を調製する場合、酸の
添加量は用いる酸により異なるが、酸の水溶液のP)1
が1〜5好ましくは2〜4になるよう調製すれば良い。Here, when preparing an aqueous solution containing an acid, the amount of acid added varies depending on the acid used, but P)1 of the aqueous acid solution
It may be adjusted so that the number is 1 to 5, preferably 2 to 4.
まtコ、皮膜剤の溶解方法は通常一般に使用されている
攪拌機(例えばプロペラ型、糧型、タービン型攪拌機)
を用いることにより十分実用的な成膜剤濃度のコーテイ
ング液の調製が可能である。The method for dissolving the coating agent is usually a commonly used stirrer (e.g. propeller type, food type, turbine type stirrer).
By using this method, it is possible to prepare a coating solution with a sufficiently practical film-forming agent concentration.
また、このコーテイング液には、必要に応じて乳糖、シ
ョ糖、デキスl−’Jン等の製剤添加物あるいはタルク
、ベントティト、食用色素等のコーティング剤を加えで
も良い。このようにして調製したコーテイング液を通常
のコーチインク方法(パンコーティング、流動層コーテ
ィング等)により錠剤あるいは粒状物に被覆することに
より本発明に係わる被覆薬剤を製造することができる。In addition, to this coating liquid, if necessary, formulation additives such as lactose, sucrose, and dextrose, or coating agents such as talc, benthite, and food coloring may be added. The coated drug according to the present invention can be produced by coating tablets or granules with the coating liquid thus prepared by a conventional coach ink method (pan coating, fluidized bed coating, etc.).
このようにしで調製した被覆薬剤は服用時十分薬剤のマ
スキング効果を示し、かつ酸性液中においては速やかな
崩壊を与え、従来の有機溶媒を用いtコ場合と同様な被
覆効果を示した。The coated drug prepared in this way showed sufficient drug masking effect when taken, and also rapidly disintegrated in acidic liquid, showing the same coating effect as in the conventional case using an organic solvent.
また、本コーティング条件はコーティング溶媒に水を用
いでいるところから、これまでの有機溶媒を用いたコー
ティング条件とは異なり、コーティング時の静電気をこ
よるコーティング障害がなく且、被覆効率の増大といっ
た特徴も有することが判った。In addition, since this coating condition uses water as the coating solvent, unlike conventional coating conditions that use organic solvents, there is no coating failure due to static electricity during coating, and the coating efficiency is increased. It was found that it also has
以五に実施例を上げτ本発明を具体的に説明するが、本
発明はこれによって限定されるものではない。Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.
なお、以Fに示す実施例中の崩壊試験は第10改正日本
薬局方一般試験法第33、崩壊試験により実施し、試験
液には第1液を使用した。In addition, the disintegration test in the examples shown in F below was conducted according to the 10th revised Japanese Pharmacopoeia General Test Method No. 33, disintegration test, and the first solution was used as the test solution.
実施例1
(コーテイング液の調製)
精 製 水 9゛5.5部
り エ ン酸 0.5部
A E A 4.0部
上記組成比になるよう)こ精製水にクエン酸を溶解させ
、(PH2,5)ひきつづきAEAを溶解すせ、コーテ
イング液を調製した。Example 1 (Preparation of coating solution) Purified water 9゛5.5 parts Citric acid 0.5 part AEA 4.0 parts Dissolve citric acid in the purified water so that the above composition ratio is achieved, (PH2,5) Subsequently, AEA was dissolved to prepare a coating solution.
(コーティング)
主薬成分とじてスルピリド1004/lを含有する乳糖
−デンプン系顆粒を常法により0、8 mm 11スク
リーンを有する円筒造粒磯を用いて湿式造粒しスルピリ
ド含有の顆粒を製した。その後12〜48メツシユの部
分を用いで、つぎは示す条件により上記コーテイング液
による被櫨操作を行ない胃溶性被覆顆粒を得た。(Coating) Lactose-starch granules containing 1004/l of sulpiride as the main ingredient were wet-granulated in a conventional manner using a cylindrical granulation iron having a 0.8 mm 11 screen to produce sulpiride-containing granules. Thereafter, using a portion of 12 to 48 meshes, a coating operation was performed using the above-mentioned coating solution under the conditions shown to obtain gastric soluble coated granules.
被覆条件:
□□ 2 、。啓えよ、
7 o −:l−9””F L 20型スプレーガン
: ノズル径Q、 g ytmのエアースプレー型
液送ポンプ : ギヤ式ポンプ
被覆液温度 = 23°C
顆粒仕込量 :1kg
被覆液供給速度:15+++7/分
スプレー空気量:6017分
給気温度 : 80°C
被覆操作時間: 70分
被覆液使用量:1kg
このようにして被覆することfこより1yあたり約80
Wの被覆が施された胃溶性被覆顆粒を得た。Covering conditions: □□ 2. Reveal, 7 o -: l-9"" F L 20 type spray gun: Air spray type liquid feed pump with nozzle diameter Q, gytm: Gear pump Coating liquid temperature = 23°C Granule charge amount: 1 kg Coating liquid Supply rate: 15+++7/min Spray air amount: 6017 min Supply air temperature: 80°C Coating operation time: 70 min Coating liquid usage: 1 kg Coating in this way: approx.
Gastric soluble coated granules coated with W were obtained.
この被覆顆粒は服用時スルピリドの謔味を感じず、良好
な服用感を示しtコ。These coated granules do not taste like sulpiride when taken, and have a good feeling when taken.
また崩壊試験結果は崩壊時間5〜7分を示し、速やかに
崩壊しrこ。In addition, the disintegration test results showed a disintegration time of 5 to 7 minutes, indicating that the product disintegrated quickly.
実施例2
(コーテイング液の調製)
精製水 96.7部
酒石酸 0.3部
AEA8.0部
上記組成比になるよゲに精製水に酒石酸を溶解させ(P
H8,7)ひきつづきAEAを溶解させコーテイング液
を調製した。Example 2 (Preparation of coating solution) Purified water 96.7 parts Tartaric acid 0.3 parts AEA 8.0 parts Tartaric acid was dissolved in purified water (P
H8, 7) Subsequently, AEA was dissolved to prepare a coating liquid.
(コーティング)
実施例1と同一条件により、上記コーテイング液を用い
で被覆することにより1gあたり約20■の被覆が施さ
れた胃溶性被覆顆粒を得た。(Coating) Under the same conditions as in Example 1, gastric soluble coated granules with a coating of about 20 μm/g were obtained by coating with the above coating solution.
この被覆顆粒は服用時、スルピリドの謔味を感じず良好
な服用感を示しrコ。また崩壊試験結果は崩壊時間4〜
6分を示し、速やかに崩壊しrこ。When taking these coated granules, they do not taste like sulpiride and have a good feeling when taken. In addition, the disintegration test results show that the disintegration time is 4~
It showed 6 minutes and immediately collapsed.
実施例3
(コーテイング液の調製)
精 製 水 95.7部
クエン酸 0.3部
オイドラギッρ堅 4.0 部上記糾成比
になるように精製水にクエン酸を溶解させ(PH2,8
)ひきつづきオイドラギット鰹を溶解させ・−ティング
液を調製しto。Example 3 (Preparation of coating liquid) Purified water 95.7 parts Citric acid 0.3 parts Eudragit ρ hard 4.0 parts Citric acid was dissolved in purified water to the above-mentioned compaction ratio (PH 2.8
) Continue to dissolve the Eudragit bonito and prepare a liquid solution.
(コーティング)
実施例1と同一条件により、上記コーテイング液を用い
て被覆することにより、1gあたり約5ottyの被覆
が施こされた胃溶性被覆顆粒を得た。(Coating) Gastric soluble coated granules were obtained by coating with the above coating liquid under the same conditions as in Example 1, with a coating of about 5 otty per gram.
この被覆顆粒は服用時スルピリドの苦味を感じず、良好
な服用感を示した。また崩壊試験結果は崩壊時間4〜6
分を示し、速やかに崩壊した。The coated granules did not taste the bitter taste of sulpiride when taken, and had a good feeling when taken. In addition, the disintegration test results show that the disintegration time is 4 to 6.
minutes and promptly collapsed.
実施例4
(コーテイング液の調製)
精製水 95.7部
クエン酸 0.3部
A E A 4.0部
上記組成比になるように精製水にクエン酸を溶解させ(
PH2,8)ひきつづきAEAを溶解させコーテイング
液を調製しtコ。Example 4 (Preparation of coating liquid) Purified water 95.7 parts Citric acid 0.3 parts A E A 4.0 parts Citric acid was dissolved in purified water so that the above composition ratio was obtained (
PH2, 8) Continue to dissolve AEA to prepare a coating solution.
(コーティング)
1錠中スルピリド200#を含有する直径9M11錠当
り重量240〜の錠剤に、つぎに示す条件で被覆操作を
行ない胃溶性被覆錠剤を得た。(Coating) Tablets with a diameter of 9M and a weight of 240~ per 11 tablets containing 200# of sulpiride in one tablet were coated under the following conditions to obtain gastric soluble coated tablets.
被覆条件:
被覆装置 : ・・RM業社製、・・、・−3−”f(
CT−60型
スプレーガン : ノズル径1.2 NMの エアー
スプレー型
液送ポンプ : ゛ギル式ポンプ
被覆液温度 = 28°C
錠剤仕込量 :18kg
被覆液供給速度:90m11分
スプレー空気流風:2201/分
給気温度 = 70°C
被覆操作中錠剤温度:88〜41℃
被覆操作時間: 140分
被覆液使用量: 121
このようして被覆することにより1錠あrこり約4ツの
被覆が施された胃溶性被覆錠剤を得た。Coating conditions: Coating equipment: ・・Manufactured by RM Industry Co., Ltd.・・・−3−”f(
CT-60 type spray gun: Nozzle diameter 1.2 NM Air spray type liquid feed pump: Gil type pump Coating liquid temperature = 28°C Tablet loading amount: 18 kg Coating liquid supply rate: 90 m 11 minutes Spray air flow Wind: 2201 / Temperature of supplied air = 70°C Tablet temperature during coating operation: 88 to 41°C Coating operation time: 140 minutes Amount of coating liquid used: 121 By coating in this manner, approximately 4 coats per tablet were coated. Gastric soluble coated tablets were obtained.
4〜8分を示し、速やかに崩壊した。It took 4 to 8 minutes and rapidly disintegrated.
実施例5
(コーテイング液の調製)
精 製 水 85.7部
クエン酸 0.8部
A E A 4.0部
乳 糖 10.0部
上記組成になるように精製水にクエン酸を溶解させ(P
H2,8)ひきつづきAEA、乳糖を溶解しコーテイン
グ液を調製した。Example 5 (Preparation of coating liquid) Purified water 85.7 parts Citric acid 0.8 parts AEA 4.0 parts Lactose 10.0 parts Citric acid was dissolved in purified water to have the above composition ( P
H2, 8) Subsequently, AEA and lactose were dissolved to prepare a coating solution.
(コーティング)
実施例4と同一条件により、上記コーテイング液を用い
で被覆することにより、1錠あたりAEAとして81q
の被覆が施こされた胃溶性被覆錠剤を得た。(Coating) By coating with the above coating liquid under the same conditions as in Example 4, 81q of AEA was obtained per tablet.
Gastric soluble coated tablets were obtained.
この被覆錠剤は服用時スルピリドの旌味を感じず良好な
服用感を示した。The coated tablets did not taste like sulpiride and had a good feeling when taken.
また崩壊試験結果は崩壊時間4〜7分を示し、速やかに
崩壊した。Moreover, the disintegration test results showed that the disintegration time was 4 to 7 minutes, and the product disintegrated quickly.
Claims (1)
有した水溶液を溶解させてなる溶液を用いて固形製剤を
被覆することを特徴とする被覆薬剤の製造方法。 (2)酸が有機酸である特許請求の範囲第1項記載の被
覆薬剤の製造方法。 (8)酸を含有した水溶液のPHが1〜5の範囲である
特許請求の範囲第1項または第2項記載の被覆薬剤の製
造方法。[Scope of Claims] (1) A coating agent characterized in that a solid preparation is coated with a solution obtained by dissolving a water-insoluble, gastric juice-soluble polymer coating agent in an acid-containing aqueous solution. manufacturing method. (2) The method for producing a coated chemical according to claim 1, wherein the acid is an organic acid. (8) The method for producing a coated chemical according to claim 1 or 2, wherein the pH of the acid-containing aqueous solution is in the range of 1 to 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22260582A JPS59110628A (en) | 1982-12-17 | 1982-12-17 | Preparation of drug coated with coating soluble in stomach |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22260582A JPS59110628A (en) | 1982-12-17 | 1982-12-17 | Preparation of drug coated with coating soluble in stomach |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS59110628A true JPS59110628A (en) | 1984-06-26 |
Family
ID=16785076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22260582A Pending JPS59110628A (en) | 1982-12-17 | 1982-12-17 | Preparation of drug coated with coating soluble in stomach |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59110628A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62127356A (en) * | 1984-10-24 | 1987-06-09 | クロンプトン・アンド・ノウルス・コ−ポレ−シヨン | Aqueous lake pigment suspension composition |
EP0247634A2 (en) * | 1986-05-30 | 1987-12-02 | Warner-Lambert Company | Coated dosage forms |
JPS63183529A (en) * | 1986-10-22 | 1988-07-28 | ビオメディカ・フォスカマ・インデュストリア・キミコ−ファルマチエウティカ・エッセ・ピ・ア | Release-controlled tablet type medicinal preparation based on buflomedil hydrochloride and manufacture |
JP2021104974A (en) * | 2019-12-26 | 2021-07-26 | 東和薬品株式会社 | Febuxostat formulation |
-
1982
- 1982-12-17 JP JP22260582A patent/JPS59110628A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62127356A (en) * | 1984-10-24 | 1987-06-09 | クロンプトン・アンド・ノウルス・コ−ポレ−シヨン | Aqueous lake pigment suspension composition |
EP0247634A2 (en) * | 1986-05-30 | 1987-12-02 | Warner-Lambert Company | Coated dosage forms |
JPS63183529A (en) * | 1986-10-22 | 1988-07-28 | ビオメディカ・フォスカマ・インデュストリア・キミコ−ファルマチエウティカ・エッセ・ピ・ア | Release-controlled tablet type medicinal preparation based on buflomedil hydrochloride and manufacture |
JP2021104974A (en) * | 2019-12-26 | 2021-07-26 | 東和薬品株式会社 | Febuxostat formulation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5723151A (en) | Cellulose acetate phthalate enteric coating compositions | |
RU2528095C2 (en) | Systems of film coating for preparations with immediate release, creating enhanced anti-moisture barrier, and substrates with such coating | |
CN101111230B (en) | Multiparticulate pharmaceutical form comprising pellets having a modular effect in relation to active ingredient release | |
US10836836B2 (en) | Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid preparation | |
EP3023110B1 (en) | Solution for spray drying comprising hypromellose acetate succinate and method for producing solid dispersion | |
DE60210552T2 (en) | Process for the preparation of a solid pharmaceutical preparation containing a sparingly soluble active substance | |
EP2813218B1 (en) | Method for producing aqueous enteric coating liquid, solid preparation, and method for producing same | |
JP2002525313A (en) | Aqueous enteric coating composition with low gastric permeability | |
JPH08109125A (en) | Production of solid enteric pharmaceutical preparation | |
EP0720473A1 (en) | Budesonide pellets with a controlled release pattern and process for producing them | |
WO2000024423A1 (en) | Sustained-release particles | |
JPH07509702A (en) | pellet drug composition | |
EP1748764A2 (en) | An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production | |
JP2007522258A (en) | Composition for oral administration of tamsulosin hydrochloride and sustained release granule preparation thereof | |
JPS59110628A (en) | Preparation of drug coated with coating soluble in stomach | |
JPH0776517A (en) | Composition for medicine | |
JPS6335526A (en) | Polymer treated ion exchange resin | |
CN111789960A (en) | Enteric coating composition, solid preparation and method for producing solid preparation | |
DE2732335A1 (en) | NEW PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
KR870000404B1 (en) | Process for preparing enteric coating solution | |
JPS58172311A (en) | Prolonged pharmaceutical preparation and its preparation | |
WO1991006291A1 (en) | Sustained release preparation | |
CN104013580B (en) | Lansoprazole micropill, capsule and preparation method thereof | |
JP3718398B2 (en) | Film coating agent and oral solid preparation | |
JP2000095709A (en) | Aqueous coating agent and production of solid pharmaceutical formulation |